麻豆女优

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Medicaid Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • 麻豆女优 Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Emergency Room Boarding
  • Device Coverage by Medicare
  • Planned Parenthood Funding
  • Covid/Flu Combo Shot
  • RFK Jr. vs. Congress

TRENDING TOPICS:

  • Emergency Room Boarding
  • Device Coverage by Medicare
  • Planned Parenthood Funding
  • Covid/Flu Combo Shot
  • RFK Jr. vs. Congress

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Friday, Sep 4 2020

Full Issue

'Very, Very Low Chance': Top Vaccine Adviser Downplays Chance Of Early Approval

Dr. Moncef Slaoui, the chief scientific adviser for the White House's "Operation Warp Speed" vaccine program, spoke to NPR about the possibility that a COVID-19 vaccine could be granted Emergency Use Authorization before final clinical trials wrap up: "I think it's extremely unlikely but not impossible."

The Centers for Disease Control and Prevention is asking states to have a plan in place to distribute a COVID-19 vaccine as soon as late October 鈥 but that doesn't mean an effective treatment will be ready quite so soon. In separate interviews Thursday with NPR, the chief scientific adviser to the Trump administration's vaccine development effort and the former director of the CDC's office of public health preparedness cautioned that an effective vaccine is likely still months away. (Silva, 9/3)

Dr. Slaoui confirmed that the two main candidates, referred to as Vaccine A and Vaccine B, were being developed by Pfizer and Moderna. He said that there was 鈥渘o intent鈥 to introduce a vaccine before clinical trials were completed, and that trials would only be completed when an independent safety monitoring board, separate from the government, affirmed the effectiveness of the vaccine. (9/3)

Talking to ScienceInsider today, Slaoui insisted he won鈥檛 be swayed by political pressures to rush an unsafe or ineffective vaccine, and that science will carry the day鈥攐r he鈥檒l quit. Slaoui has given few interviews since taking the Warp Speed job and he has taken something of a beating in the media for his financial holdings in companies working on COVID-19 vaccines鈥攈e was on the board of Moderna and has since stepped down, but he retains his GlaxoSmithKline stock. And Warp Speed has been slammed for a lack of transparency on its decisions. (Cohen, 9/3)

Dr. Anthony Fauci weighs in 鈥

Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, said Thursday that he believes federal regulators will allow a coronavirus vaccine to be distributed this fall only if it鈥檚 based on science and 鈥渉ard data.鈥 Fauci made the assessment after the disclosure of an Aug. 27 letter from the Centers for Disease Control and Prevention that told states to prepare for the 鈥渓arge-scale鈥 distribution of a vaccine by Nov. 1, two days before the presidential election. (Stelloh and Allen, 9/3)

Anthony Fauci, the nation鈥檚 leading infectious diseases expert, said he would feel comfortable taking a coronavirus vaccine if one is approved by the government.聽鈥淚 mean I will look at the data and I would assume and I鈥檓 pretty sure it鈥檚 going to be the case that a vaccine would not be approved for the American public unless it was indeed both safe and effective. And I keep emphasizing both safe and effective. If that鈥檚 the case, Jim, I would not hesitate for a moment to take the vaccine myself and recommend it for my family,鈥 he told CNN anchor Jim Sciutto on Thursday. (Axelrod, 9/3)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, April 24
  • Thursday, April 23
  • Wednesday, April 22
  • Tuesday, April 21
  • Monday, April 20
  • Friday, April 17
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

漏 2026 麻豆女优